BlackRock’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-176,830
Closed -$1.04M 5488
2023
Q4
$1.04M Buy
176,830
+22,067
+14% +$261K ﹤0.01% 4241
2023
Q3
$3.92M Sell
154,763
-6,476
-4% -$532K ﹤0.01% 3752
2023
Q2
$22.4M Buy
161,239
+46,991
+41% +$6.03M ﹤0.01% 2970
2023
Q1
$10.4M Sell
114,248
-4,910
-4% -$667K ﹤0.01% 3302
2022
Q4
$16.3M Sell
119,158
-6,901
-5% -$2.34M ﹤0.01% 3146
2022
Q3
$109M Sell
126,059
-3,311
-3% -$2.08M ﹤0.01% 1900
2022
Q2
$56.7M Buy
129,370
+74,500
+136% +$38.9M ﹤0.01% 2397
2022
Q1
$34.8M Buy
54,870
+8,015
+17% +$5.05M ﹤0.01% 2804
2021
Q4
$41.7M Buy
46,855
+11,094
+31% +$11.7M ﹤0.01% 2773
2021
Q3
$45.3M Sell
35,761
-58,376
-62% -$70.7M ﹤0.01% 2726
2021
Q2
$114M Buy
94,137
+86,913
+1,203% +$117M ﹤0.01% 2172
2021
Q1
$9.57M Buy
7,224
+4,389
+155% +$6.21M ﹤0.01% 3599
2020
Q4
$3.8M Buy
+2,835
New +$3.24M ﹤0.01% 3811

Other funds holding CANO

BlackRock's CANO Position: Q1 2024 in Review

BlackRock sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 176,830 shares — an estimated $1.04M sold.

BlackRock first reported a position in CANO in Q4 2020 and held it in 13 quarters. The position peaked at $114M in Q2 2021. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • BlackRock reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • BlackRock sold 176,830 Cano Health, Inc. shares in Q1 2024, an estimated $1.04M.
  • BlackRock first reported a position in Cano Health, Inc. in Q4 2020 and held it in 13 quarters.
  • BlackRock's Cano Health, Inc. position peaked at $114M in Q2 2021.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.